Clinical Research Directory
Browse clinical research sites, groups, and studies.
The German ADPKD Tolvaptan Treatment Registry
Sponsor: University of Cologne
Summary
The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide "real-world" data on treatment management of patients with ADPKD.
Official title: The German ADPKD Tolvaptan Treatment Registry is a Prospective, Observational, Multicentric Study of Patients Suffering From ADPKD That Are Considered for Tolvaptan Treatment.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2015-11
Completion Date
2027-12
Last Updated
2024-12-11
Healthy Volunteers
No
Locations (12)
Fachinternistische Gemeinschaftspraxis Markgraeferland
Müllheim, Baden-Wurttemberg, Germany
University Hospital of Wuerzburg, ZIM
Würzburg, Bavaria, Germany
Medizinische Hochschule Hannover
Hanover, Lower Saxony, Germany
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany
Nieren- und Diabeteszentrum Nettetal-Lobberich
Nettetal, North Rhine-Westphalia, Germany
University Hospital of Leipzig, Nephrologische Ambulanz
Leipzig, Saxony, Germany
Praxisgemeinschaft Dr. Peschel
Leipzig, Saxony, Germany
University Hospital of Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany
Nierenzentrum Lübeck
Lübeck, Schleswig-Holstein, Germany
University Hospital of Jena
Jena, Thuringia, Germany
Charité Universitätsmedizin Berlin
Berlin, Germany
Robert-Bosch-Krankenhaus
Stuttgart, Germany